«An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer». Therapeutic Advances in Urology, vol. 3, 3, 6-2011, pàg. 127–40. DOI: 10.1177/1756287211414457. PMC: 3159401. PMID: 21904569.
drugs.com
«Abarelix». Drugs.com. Arxivat de l'original el 2018-02-10. [Consulta: 7 agost 2021].
«An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer». Therapeutic Advances in Urology, vol. 3, 3, 6-2011, pàg. 127–40. DOI: 10.1177/1756287211414457. PMC: 3159401. PMID: 21904569.